ARTICLE | Company News
Applied NeuroSolutions, Eli Lilly deal
December 4, 2006 8:00 AM UTC
LLY and APNS partnered to develop therapeutics to treat Alzheimer's disease (AD). LLY will have exclusive worldwide rights to APNS's IP related to the molecular neuropathology of AD as it pertains to ...